Respiratorius
1.73 SEK
+4.55 %
Less than 1K followers
RESP
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+4.55 %
-8.97 %
-52.08 %
-78.38 %
-73.46 %
-53.13 %
-96.46 %
-99.03 %
-87.95 %
Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.
Read moreMarket cap
13.63M SEK
Turnover
5.38K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
10/2
2026
Annual report '25
All
Press releases
ShowingAll content types
Respiratorius: Delårsrapport 3, 2025
Sista dag för handel med BTA i Respiratorius
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools